Agios Pharmaceuticals (AGIO) is down -47.4%, or -$21.54 to $23.95.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGIO:
- Morning Movers: Semrush skyrockets after deal to be bought by Adobe
- Agios reports RISE UP Phase 3 trial of mitapivat met primary endpoint
- Agios Pharmaceuticals announces new data on mitapivat
- Agios Pharmaceuticals’ Earnings Call: Growth and Challenges
- Agios Pharmaceuticals Reports Q3 2025 Financial Results